GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lumosa Therapeutics Co Ltd (ROCO:6535) » Definitions » Other Current Liabilities

Lumosa Therapeutics Co (ROCO:6535) Other Current Liabilities : NT$157.17 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Lumosa Therapeutics Co Other Current Liabilities?

Lumosa Therapeutics Co's other current liabilities for the quarter that ended in Jun. 2024 was NT$157.17 Mil.

Lumosa Therapeutics Co's quarterly other current liabilities increased from Dec. 2023 (NT$156.94 Mil) to Mar. 2024 (NT$157.20 Mil) but then declined from Mar. 2024 (NT$157.20 Mil) to Jun. 2024 (NT$157.17 Mil).

Lumosa Therapeutics Co's annual other current liabilities increased from Dec. 2021 (NT$157.74 Mil) to Dec. 2022 (NT$160.35 Mil) but then declined from Dec. 2022 (NT$160.35 Mil) to Dec. 2023 (NT$156.94 Mil).


Lumosa Therapeutics Co Other Current Liabilities Historical Data

The historical data trend for Lumosa Therapeutics Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumosa Therapeutics Co Other Current Liabilities Chart

Lumosa Therapeutics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lumosa Therapeutics Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lumosa Therapeutics Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Lumosa Therapeutics Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Lumosa Therapeutics Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumosa Therapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
Yuanyuan Street, 4th Floor, No. 3-2, Nangang District, Taipei, TWN, 11503
LUMOSA THERAPEUTICS CO LTD develops new drugs. The company is engaged in the development of drugs for unmet medical needs in the fields of CNS, oncology, and inflammatory diseases. Geographically, it derives a majority of its revenue from Asia and also has a presence in Taiwan and America. Its product portfolio includes LT - 1001 and LT - 3001 for Analgesic Injection and Novel Small Molecules for the Treatment of Acute Ischemic Stroke.

Lumosa Therapeutics Co Headlines

No Headlines